Cargando…

Proton pump inhibitors as a risk factor for norovirus infection

Norovirus causes viral gastroenteritis, which is a major problem in health care. The disease causes death in elderly and seriously ill patients, and results in significant health costs each year. Proton pump inhibitors (PPIs) reduce gastric acidity, which is an important protection against microorga...

Descripción completa

Detalles Bibliográficos
Autores principales:	PRAG, C., PRAG, M., FREDLUND, H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2017
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426289/ https://www.ncbi.nlm.nih.gov/pubmed/28325163 http://dx.doi.org/10.1017/S0950268817000528

Ejemplares similares

Antibiotic treatment with one single dose of gentamicin at admittance in addition to a β-lactam antibiotic in the treatment of community-acquired bloodstream infection with sepsis
por: Liljedahl Prytz, Karolina, et al.
Publicado: (2020)

Cultural determinants influence assisted reproduction usage in Europe more than economic and demographic factors
por: Präg, Patrick, et al.
Publicado: (2017)

Proton Pump Inhibitor Use and Risk of Serious Infections in Young Children
por: Lassalle, Marion, et al.
Publicado: (2023)

Proton Pump Inhibitors are Risk Factors for Viral Infections: Even for COVID-19?
por: Charpiat, Bruno, et al.
Publicado: (2020)

Delirium in the geriatric unit: proton-pump inhibitors and other risk factors
por: Otremba, Iwona, et al.
Publicado: (2016)

Risk of small intestinal bacterial overgrowth in patients receiving proton pump inhibitors versus proton pump inhibitors plus prokinetics
por: Revaiah, Pruthvi C, et al.
Publicado: (2018)

Lemierre’s syndrome and other disseminated Fusobacterium necrophorum infections in Denmark: a prospective epidemiological and clinical survey
por: Hagelskjær Kristensen, L., et al.
Publicado: (2008)

Subjective socio-economic status predicts self-rated health irrespective of objective family socio-economic background
por: Präg, Patrick
Publicado: (2020)

Educational inequalities in self-rated health across US states and European countries
por: Präg, Patrick, et al.
Publicado: (2017)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Dexlansoprazole – a new-generation proton pump inhibitor
por: Skrzydło-Radomańska, Barbara, et al.
Publicado: (2015)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19
por: Homolak, Jan, et al.
Publicado: (2021)

Risk of Pyogenic Liver Abscess in Proton Pump Inhibitor Users: New Inventory of Proton Pump Inhibitor Induced Complications?
por: Bang, Ki Bae
Publicado: (2021)

Influence of Proton Pump Inhibitors on Dexamethasone-Induced Gastric Mucosal Damage in Rats
por: Swamy, A. H. M. Viswanatha, et al.
Publicado: (2011)

Proton Pump Inhibitors and the Risk of Adverse Cardiac Events
por: Juurlink, David N., et al.
Publicado: (2013)

Association of Proton Pump Inhibitor Use With Risk of Acquiring Drug-Resistant Enterobacterales
por: Willems, Roel P. J., et al.
Publicado: (2023)

Molecular phylogeny of the kelch-repeat superfamily reveals an expansion of BTB/kelch proteins in animals
por: Prag, Soren, et al.
Publicado: (2003)

The Association of Diuretics and Proton Pump Inhibitors With Chondrocalcinosis
por: Felson, David T., et al.
Publicado: (2021)

Heterogeneous mental health development during the COVID-19 pandemic in the United Kingdom
por: Ellwardt, Lea, et al.
Publicado: (2021)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Anti-infective properties of proton pump inhibitors: perspectives
por: da Rosa, Taciéli Fagundes, et al.
Publicado: (2021)

Proton pump inhibitors: Review of reported risks and controversies
por: Brisebois, Simon, et al.
Publicado: (2018)

Proton pump inhibitors increase risk of COVID-19
Publicado: (2020)

Use of proton pump inhibitors for the risk of gastric cancer
por: Gao, Huiqin, et al.
Publicado: (2022)

Proton-Pump Inhibitor Use and the Risk of Community-Associated Clostridium difficile Infection
por: Inghammar, Malin, et al.
Publicado: (2021)

Increased risk of biliary infection after biliary stent placement in users of proton pump inhibitors
por: Hakuta, Ryunosuke, et al.
Publicado: (2022)

Safe use of proton pump inhibitors in patients with cirrhosis
por: Weersink, Rianne A., et al.
Publicado: (2018)

Attitudes towards embryo donation in Swedish women and men of reproductive age
por: Wånggren, Kjell, et al.
Publicado: (2013)

Proton Pump Inhibitor Usage and the Risk of Mortality in Hemodialysis Patients
por: de Francisco, Angel L.M., et al.
Publicado: (2017)

Mechanisms of proton pump inhibitor‐induced hypomagnesemia
por: Gommers, Lisanne M. M., et al.
Publicado: (2022)

Effects of Proton Pump Inhibitors on Lung Cancer Precise Radiotherapy-Induced Radiation Pneumonitis
por: Su, QiaoLi, et al.
Publicado: (2014)

Is the Use of Proton Pump Inhibitors a Predisposing Factor for Pyogenic Liver Abscesses?
por: Elfiky, Ahmed, et al.
Publicado: (2021)

Evaluation of Fluid Responsiveness: Is Photoplethysmography a Noninvasive Alternative?
por: Antonsen, Lars Prag, et al.
Publicado: (2012)

Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy
por: Nishizawa, Toshihiro, et al.
Publicado: (2012)

Proton pump inhibitors increase the chemosensitivity of patients with advanced colorectal cancer
por: Wang, Xiaoyu, et al.
Publicado: (2017)

Do Proton Pump Inhibitors Decrease Calcium Absorption?
por: Hansen, Karen E, et al.
Publicado: (2010)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6ukn4th1rgm98ra2artglaeplh